Recent Analysts’ Ratings Updates for Afya (AFYA)

Posted by on Nov 3rd, 2026

A number of firms have modified their ratings and price targets on shares of Afya (NASDAQ: AFYA) recently:

  • 11/3/2026 – Afya was upgraded by Citigroup from “neutral” to “buy”. They now have a $12.00 price target on the stock, down from $16.00.
  • 11/3/2026 – Afya had its price target lowered by JPMorgan Chase & Co. from $19.00 to $17.50. They now have an “overweight” rating on the stock.
  • 10/31/2026 – Afya was downgraded by Wall Street Zen from “buy” to “hold”.
  • 10/29/2026 – Afya was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
  • 10/29/2026 – Afya was upgraded by Bank of America from “neutral” to “buy”. They now have a $16.00 price target on the stock.
  • 10/7/2026 – Afya was upgraded by JPMorgan Chase & Co. from “neutral” to “overweight”. They now have a $19.00 price target on the stock, down from $21.00.
  • 10/5/2026 – Afya was upgraded by Zacks Research from “strong sell” to “hold”.
  • 9/24/2026 – Afya was upgraded by Bradesco Corretora to “outperform”. They now have a $17.00 price target on the stock.
  • 9/5/2026 – Afya was upgraded by Wall Street Zen from “hold” to “buy”.

Afya Stock Down 0.8%

Shares of NASDAQ AFYA traded down $0.09 during trading on Tuesday, hitting $10.55. The stock had a trading volume of 411,473 shares, compared to its average volume of 191,712. Afya Limited has a 12 month low of $9.66 and a 12 month high of $16.16. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The company has a market capitalization of $988.78 million, a PE ratio of 6.43, a PEG ratio of 1.24 and a beta of 0.34. The firm has a fifty day moving average of $13.55 and a two-hundred day moving average of $14.18.

Afya (NASDAQ:AFYA – Get Free Report) last announced its earnings results on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. Afya had a net margin of 20.55% and a return on equity of 17.58%. The company had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. As a group, equities research analysts forecast that Afya Limited will post 1.72 EPS for the current fiscal year.

Insider Transactions at Afya

In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of the stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the sale, the insider owned 35,000 shares in the company, valued at approximately $465,500. This trade represents a 10.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.80% of the company’s stock.

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.

Read More

Receive News & Ratings for Afya Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya Limited and related companies with MarketBeat.com's FREE daily email newsletter.